-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Thematic Analysis
NewMedical Devices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Medical Devices Sector
-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Sector Analysis
NewResistant Hypertension (RH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Resistant Hypertension (RH) Marketed and Pipeline Drugs Report Overview Resistant Hypertension (RH) refers to high blood pressure (BP) that is above the target level in a patient. This occurs even when they are taking three different classes of antihypertensive medications concurrently. These medication classes typically include diuretics, long-acting calcium channel blockers, and renin-angiotensin system blockers (ACEs or ARBs). The Resistant Hypertension (RH) marketed, and pipeline drugs research report includes an assessment of the disease epidemiology, leading marketed products with sales...
-
Innovation Ranking
Innovation Ranking – 10X Genomics Inc
10X Genomics Inc (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises chromium X series, chromium connect, and chromium controller. It offers services such as single-cell gene expression, single-cell immune profiling, fixed RNA profiling, single-cell multiome ATAC + gene expression, spatial gene expression, and targeted gene expression. The company also provides Barcode technology which is compatible with Single Cell Gene Expression and Immune Profiling solutions allowing researchers to simultaneously measure multiple analytes, such as...
-
Innovation Ranking
Innovation Ranking – BGI Genomics Co Ltd
BGI Genomics Co Ltd (BGI Genomics), a subsidiary of Beijing BGI-GBI Biotech Co Ltd BGI, provides next generation sequencing services and genetic tests. The company offers services including DNA (deoxyribonucleic acid) sequencing, RNA (ribonucleic acid) sequencing, non-invasive prenatal testing, newborn genetic screening, reproductive health screening, customized sequencing services and clinical exome sequencing services. BGI Genomics also conducts research to advance precision medicine and diagnostics in the fields of metagenomics, reproductive health and for detecting cancer. It serves various medical institutions,...
-
Innovation Ranking
Innovation Ranking – BioNano Genomics Inc
BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include Saphyr optical genome mapping instrument, bionano chips, bionano sample prep kits and bionano data solutions. BioNano’s prep kits are optimized to extract and label DNA for genome mapping systems. The company also offers data solutions which provide experiment management, analysis, and bioinformatics processing. It conducts research across various areas including human disease, agricultural bioengineering and...
-
Product Insights
Borderline Personality Disorder (BPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Borderline Personality Disorder (BPD) Clinical Trial Report Overview A total of 71 borderline personality disorder (BPD) clinical trials were conducted as of March 2024. The borderline personality disorder (BPD) clinical trial report provides a comprehensive understanding of the borderline personality disorder (BPD) clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with...
-
Product Insights
Likelihood of Approval Analysis for Mutational Disorders
Overview How likely is it that the drugs in Mutational Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mutational Disorders Overview Mutational disorders, alternatively termed genetic or genomic disorders, stem...